{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-005379","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.446394+00:00","generated_at":"2026-06-06T20:44:51.063395+00:00","sec_items":["2.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Clarivate launches $2.2B term loan refinancing; expects $800M-$900M goodwill impairment in Q4 2023","bullets":["Refinancing of 2026 Term Loan B with new $2.2B, 7-year facility maturing in 2031, subject to market conditions.","Expects non-cash goodwill impairment charge of $800M-$900M in Q4 2023 for IP and Life Sciences & Healthcare segments.","Impairment lowers GAAP net loss forecast but no impact on 2023 revenue, Adjusted EBITDA, or other non-GAAP guidance.","CFO states refinancing proactively extends debt maturities and improves financial flexibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-005379","json":"https://secwatch.observer/filing/0001104659-24-005379.json","markdown":"https://secwatch.observer/filing/0001104659-24-005379.md","text":"https://secwatch.observer/filing/0001104659-24-005379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000110465924005379/0001104659-24-005379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000110465924005379/tm243777d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:44:51.063395+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}